Hospital IV Set Bought For Rs 11.05, Billed At Rs 325: Maharashtra FDA Flags 2,841 Per Cent Markup

A low-cost IV set can become a surprisingly expensive entry on a hospital bill. A survey by the Maharashtra Food and Drugs Administration (FDA) found that an IV infusion set purchased by a private hospital for Rs 11.05 was billed to the patient at Rs 325.

The difference works out to a markup of about 2,841 per cent over the purchase price. The finding has brought the pricing of everyday medical consumables—items that patients seldom question during admission—under the scanner.

Maharashtra FDA Commissioner Tukaram Mundhe has reportedly asked the Centre to review the sharp gap between procurement prices and the rates eventually charged to patients.

Medical Consumables Show Wide Price Gaps

The state survey examined surgical items and medical devices commonly used for patients admitted to private hospitals. These included syringes, catheters, oxygen masks, nebulisers and IV infusion sets, according to a recent report by Moneycontrol.

In another instance, a catheter bought for Rs 29.41 carried a maximum retail price (MRP) of Rs 310. Such differences can swell the final hospital bill.

Patients are usually in no position to compare prices while treatment is underway. They may see the charge only when the final itemised bill is prepared. By then, the product has already been used, leaving little room to seek a cheaper alternative or question the rate in advance.

The survey compared the price paid by hospitals with the printed MRP or the amount charged to patients. It has raised a larger question: should hospitals and suppliers be allowed to retain such wide margins merely because a device carries a much higher printed price?

Centre Asked To Consider Margin Controls

In a communication sent on August 10 to the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority (NPPA), Mundhe sought a review of the findings and suitable regulatory action.

The suggestions reportedly include a cap on trade margins and structured monitoring of prices for essential categories of medical devices. The NPPA is also said to be examining whether manufacturers and intermediaries are adding steep margins before these products reach patients.

Drug-control authorities in Punjab, Rajasthan and Tamil Nadu have reportedly raised similar concerns, indicating that the problem may extend beyond Maharashtra.

Under the Drugs (Prices Control) Order, 2013, the NPPA fixes ceiling prices for scheduled medicines and specified medical devices. Prices of non-scheduled products are monitored, and their MRP cannot be increased by more than 10 per cent in a 12-month period. This, however, restricts annual increases; it does not impose a common ceiling price across every device category.

The regulator has previously placed coronary stents and knee implants under direct price control. Trade margins were also rationalised for oxygen concentrators and certain other devices during the Covid-19 pandemic.

What Patients Should Check

Until the pricing issue is reviewed, patients and families should ask hospitals for an itemised estimate before a planned admission and a detailed bill at discharge. The quantity, unit price and MRP of each consumable should be checked carefully.

Those using health insurance should also find out which consumables are payable under their policy and which must be borne out of pocket. Even small disposable items can add up when used repeatedly. Greater disclosure at the billing stage can help patients challenge obvious discrepancies, but regulatory scrutiny may be necessary to address the larger pricing gap.

FAQs

1. Why can inexpensive medical consumables cost much more on hospital bills?
Hospitals may bill consumables at their printed MRP or another marked-up price, even when they procured them at a substantially lower rate.

2. Are all medical devices subject to government price controls?
No. The NPPA fixes ceiling prices for specified devices, but many non-scheduled products are only monitored for annual MRP increases.

3. How can patients identify excessive charges for consumables?
Ask for an itemised estimate and final bill showing the quantity, unit price, and MRP of each item. Also check which consumables your insurer excludes.